Swipe fee reform: Just what the industry ordered
WHAT IT MEANS AND WHY IT’S IMPORTANT This represents a significant victory for retailers from all sectors, if for nothing else than it provides a little overhead cost stability in what continues to be a volatile economy.
(THE NEWS: Swipe fee fix draws praise from industry groups. For the full story, click here)
These swipe fees not only represent the fastest-growing expense to retail, but retailers also are held somewhat hostage to swipe fee increases — large banks can raise the rates at their discretion without any input from retailers beyond a retailer’s refusal to accept that particular form of payment. And with the proliferation of credit cards and debit cards among today’s consumers, refusal to carry doesn’t really represent a viable option.
According to the 2010 Debit Issuer Study, commissioned by PULSE (a Discover Financial Services company and leading ATM/debit network), the debit card market has remained robust during the second year of the economic downturn, and is projected to grow strongly in 2010. And the study determined that much of the growth in debit use is in small-ticket transactions, suggesting that more consumers prefer debit over cash.
Debit card penetration — the percentage of eligible accounts that can be accessed by a debit card — has remained steady at 73% since 2007, and as many as 64% of consumer debit cards are active. Banks surveyed experienced overall debit transaction growth of 10% between 2008 and 2009. In 2009, 58% of all debit transactions were less than $20.
"The debit market has continued to weather the economic storm as a result of consumer preference for debit and increasing merchant acceptance of small-ticket debit transactions," stated Cindy Ballard, PULSE EVP. "As consumers scaled back spending during the recession, they embraced a pay-as-you-go approach and are keeping their debit card top-of-wallet."
The Dodd-Frank Wall Street Reform and Consumer Protection Act also may prove timely for retailers. According to the aforementioned PULSE report, pending government regulations were cited by issuers as a “major challenge” for their institutions, particularly changes to Regulation E that take effect this summer. That regulation change requires bank customers to “opt-in” to allow ATM and small debit transactions to overdraw their accounts, and in so doing incur an overdraft charge.
Between interchange fees and overdraft charges, PULSE estimated each active card generates $118 in annual revenue industry-wide. And issuers expect as many as 70% of consumers to not opt in. “Financial institutions expect that the changes to Reg E will result in fewer approved transactions, lower interchange [fee] income and less profitable debit card programs, impacting debit card profitability over the next two years. In an effort to counteract potential decreased fee income, 45% of issuers have already created a plan in response to the changes,” PULSE noted in a June 14 release. And what are the chances those plans include increasing interchange fees in an effort to counterbalance declining overdraft fees?
Pampers by Cynthia Rowley hitting Target shelves in July
CINCINNATI Pampers has teamed up with renowned fashion designer Cynthia Rowley to bring fashionable diapers to Target shoppers this summer.
Pampers by Cynthia Rowley will be available in 11 colorful styles — for boys and girls — beginning in mid July at Target stores and on Target.com. Pampers by Cynthia Rowley incorporate a beautiful look and feel — giving discerning parents high performance, value and choice of style. The diaper collection, which will be available in pastel designs, including madras, stripes and printed ruffles, is suited specifically to babies and toddlers and delivers the perfect blend of utility and aesthetics.
“Of course parents want the very best for their little ones,” said Jodi Allen, Procter & Gamble’s VP North America baby care. “We also know that sometimes it’s the little things — like how a baby is clothed — that can bring added joy to mom and dad. While performance always comes first, we know that design is also important to parents. We’re pleased to introduce the first diaper line that brings together the best of these two worlds.”
Eisai, SuperGen release data for Dacogen trial
DUBLIN, Calif. Japanese drug maker Eisai has released data on a late-stage clinical trial of a drug for leukemia, Eisai’s development partner said Wednesday.
SuperGen said that while the injectable drug Dacogen (decitabine) did not show statistically significant superiority in overall survival in elderly patients with acute myeloid leukemia compared over treatments given to patients in the control group, “a trend was evident.”
Based on findings, Eisai plans to submit a regulatory application to the Food and Drug Administration seeking approval for Dacogen as a treatment for elderly patients with AML. The drug already is approved to treat myelodysplastic syndromes.